Development of an adjuvant-active nonionic block copolymer for use in oil-free subunit vaccines formulations

Vaccine

Volumn 15, Issue 5, 1997, Pages 564-570

  Todd, C W ^a   Pozzi, L A M ^a   Guarnaccia, J R ^a   Balasubramanian, M ^b   Henk, W G ^c   Younger, L E ^c   Newman, M J ^a  

^a Vaxcel Inc   (United States)

^b CytRx Corporation   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

adjuvant; copolymer; CRL1995; vaccine

Indexed keywords

ALUMINUM POTASSIUM SULFATE; COPOLYMER; CRL 1005; FREUND ADJUVANT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; IMMUNOLOGICAL ADJUVANT; OVALBUMIN; QUIL A; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; VACCINE PRODUCTION;

EID: 0030934699     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00209-0     Document Type: Article

References (47)

1. Audibert, F., Chedid, L., Lefrancier, P. and Choay, J. Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components. Cell. Immunol. 1976, 21, 243-250
2. Damais, C., Parant, M., Chedid, L., Lefrancier, P. and Choay, J. In vitro spleen cell responsiveness to various analogs of MDP (N-acetylmuramyl-l-isoglutamine), a synthetic immunoadjuvant, in MDP high-responder mice. Cell. Immunol. 1978, 35, 173-181
3. Tanaka, A., Nagao, S., Nagao, R., Kotani, S., Shiba, T. and Kusumoto, S. Stimulation of the reticuloendothelial system of mice by muramyl dipeptide. Infect. Immun. 1976, 24, 302-310
4. Gery, I., Kruger, J., Spiesel, S.Z. Stimulation of B-lymphocytes by endotoxin. Reactions of thymus-deprived mice and karyotypic analysis of dividing cell in mice bearing T6T6 thymus grafts. J. Immunol. 1972, 108, 1088-1094
5. Johnson, A.G. and Tomai, M.A. A study of the cellular and molecular mediators of the adjuvant action of a nontoxic monophosphoryl lipid A. Adv. Exp. Med. Biol. 1990, 256, 567-579
6. Tomai, M.A. and Johnson, A.G. T cell and interferon-gamma involvement in the adjuvant action of detoxified endotoxin. J. Biol. Response Modifiers 1989, 8, 625-635
7. Arend, W.P. and Massoni, R.J. Characteristics of bacterial lipopolysaccharide induction of interleukin 1 synthesis and secretion by human monocytes. Clin. Exp. Immunol. 1986, 64, 656-664
8. Flebbe, L.M. and Braley-Mullen, H. Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T dependent and T independent antigens. Cell. Immunol. 1986, 99, 119-127
9. Flebbe, L.M. and Braley-Mullen, H. Immunopotentiation by SGP and Quil A. II. Identification of responding cell populations. Cell. Immunol. 1986, 99, 128-139
10. Kensil, C.R., Patel, U., Lennick, M. and Marciani, D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. J. Immunol. 1991, 146, 431-437
11. Wu, J.-Y, Gardner, B.H. and Kushner, N.N. et al. Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes. Cell. Immunol. 1994, 154, 393-406
12. Heath, A.W. and Playfair, J.H.L. Cytokines as immunological adjuvants. Vaccine 1992, 10, 427-434
13. Tagliabue, A. and Boraschi, D. Cytokines as vaccine adjuvants: interleukin 1 and its synthetic peptide 163-171. Vaccine 1993, 11, 594-595
14. Schijns, V.E.C.J., Claassen, I.J.T.M., Vermeulen, A.A., Horzinek, M.C. and Osterhaus, A.D.M.E. Modulation of antiviral immune responses by exogenous cytokines: effects of tumour necrosis factor-α, interleukin-1α, interleukin-2 and interferon-gamma on the immunogenicity of an inactivated rabies vaccine. J. Gen. Virol. 1994, 75, 55-63
15. Alfonso, L.C.C., Scharton, T.M., Vieira, L.Q., Wysocka, M., Trinchieri, G. and Scott, P. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 1994, 263, 235-237
16. Nash, A.D., Lofthouse, S.A. and Barcham, G.J. et al. Recombinant cytokines as immunological adjuvants. Immunol. Cell Biol. 1993, 71, 367-379
17. Nohria, A. and Rubin, R.H. Cytokines as potential vaccine adjuvants. Biotherapy 1994, 7, 261-269
18. Gupta, R.K., Rost, B.E., Relyveld, E. and Siber, G.R. Adjuvant properties of aluminum and calcium compounds. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 229-248
19. Ott, G., Barchfeld, G.L., Chernoff, D., Radhakrishnan, R., van Hoogevest, P. and Van Nest, G. MF59: Design and evaluation of a safe and potent adjuvant for human vaccines. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 277-296
20. McKercher, P.D. Oil adjuvants: their use in veterinary biologics. In: Advances in Carriers and Adjuvants of Veterinary Biologics (Eds Nervig, R.M., Gough, P.M., Kaeberle, M.L. and Whetstone, C.A.). Iowa State University Press, Ames, 1986, pp. 115-135
21. Woodard, L.F. and Jasman, R.L. Stable oil-in-water emulsions: preparation and use as vaccine vehicles for lipophilic adjuvants. Vaccine 1985, 3, 137-142
22. Hilleman, M.R. Critical appraisal of emulsified oil adjuvants applied to viral vaccines. Prog. Med. Virol. 1966, 8, 131-151
23. Allison, A.C. and Gregoriadis, G. Liposomes as immunological adjuvants. Nature 1974, 252, 252-255
24. Gregoriadis, G., Davis, D. and Davies, A. Liposomes as immunological adjuvants: antigen incorporation studies. Vaccine 1987, 5, 145-151
25. Gluck, R. Liposomal presentation of antigens for human vaccines. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 325-346
26. Rudbach, J.A., Johnson, D.A. and Ulrich, J.T. Ribi adjuvants: Chemistry, biology and utility in vaccines for human and veterinary medicine. In: The Theory and Practicle Application of Adjuvants (Ed. Stewart-Tull, D.E.S.). John Wiley and Sons, New York, 1995, pp. 287-313
27. Lidgate, D.M. and Byars, N.E. Development of an emulsion-based muramyl dipeptide adjuvant formulation for vaccines. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 313-324
28. Alving, C. Lipopolysaccharides, lipid A and liposomes containing lipid A as immunologic adjuvants. Immunobiology 1993, 187, 430-446
29. Lachman, L.B., Shih, L.C.N., Rao, X.M., Ullrich, S.E. and Cleland, J.L. Cytokine-containing liposomes as adjuvants for subunit vaccines. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 659-671
30. Cleland, J.L. Design and production of single-immunization vaccines using polylactide polyglycolide microsphere systems. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 439-462
31. Eldridge, J.H., Staas, J.K., Meulbroek, J.A., McGhee, J.R., Tice, T.R. and Giller, R.M. Biodegradable microspheres as a vaccine delivery. Mol. Immunol. 1993, 28, 287-294
32. Kohn, J., Niemi, S.M., Albert, E.G., Murphy, J.C., Langer, R. and Fox, J.G. Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity. J. Immunol. Meth. 1995, 95, 31-38
33. Payne, L.G., Jenkins, S.A., Andrianov, A. and Roberts, B.E. Water-soluble phosphazene polymers for parenteral and mucosal vaccine delivery. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 473-493
34. Hunter, R.L., Olsen, M.R., and Bennett, B. Copolymer adjuvants and Titermax. In: The Theory and Practicle Application of Adjuvants (Ed. Stewart-Tull, D.E.S.). John Wiley and Sons, New York, 1995, pp. 51-94
35. Howerton, D.A., Hunter, R.L., Ziegler, H.K. and Check, I.J. The induction of macrophage la expression in vivo by synthetic copolymer L81. J. Immunol. 1990, 144, 1578-1584
36. Hunter, R.L. and Bennett, B. The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblocks and octablock copolymers. J. Immunol. 1984, 133, 3167-3175
37. Hunter, R.L., Strickland, F. and Kezdy, F. Studies on the adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile - lipophile balance. J. Immunol. 1981, 127, 1244-1250
38. Hunter, R.L. and Bennett, B. The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces. Scand. J. Immunol. 1986, 23, 287-300
39. MacLean, G.D., Reddish, M. and Koganty, R.R. et al. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Immunol. Immunother. 1993, 36, 215-222
40. Livingston, P.O., Wong, G.Y.C. and Adluri, S. et al. Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J. Clin. Oncol. 1994, 12, 1036-1044
41. Livingston, P.O., Adluri, S. and Helling, F. et al. Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine 1994, 12, 1275-1280
42. M2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. Cancer Res. 1995, 55, 2783-2788
43. Reddish, M.A., Buszynski, V., Ding, L. and Longenecker, B.M. Active specific immunotherapy of adenocarcinomas with synthetic tumor-associated antigens conjugated to keyhole limpet hemocyanin. Onkologie 1995, 18 (Suppl. 1), 33-35
44. Wu, J.-Y, Gardner, B.H. and Murphy, C.I. et al. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J. Immunol. 1992, 148, 1519-1525
45. Macdonald, R.A., Hosking, C.S. and Jones, C.L. The measurement of relative antibody affinity by ELISA using thiocyanate elution. J. Immunol. Meth. 1988, 106, 191-194
46. Kensil, C.R., Wu, J.Y. and Soltysik, S. Structural and immunological characterization of the vaccine adjuvant QS-21. In: Vaccine Design: The Subunit and Adjuvant Approach (Eds Powell, M.F. and Newman, M.J.). Plenum Press, New York, 1995, pp. 525-542
47. Mossman, T.R. and Coffman, R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. A. Rev. Immunol. 1989, 7, 145-173